SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is rallying as retail investors flock to the stock, fueled by intense momentum and viral speculation surrounding the upcoming SpaceX IPO. The community is actively discussing a potential short squeeze and high-volume trading activity, with many drawing parallels to past meme stock frenzies.

Astrotech Corp. engages in the mass spectrometry company that launches, manages and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. Its business units include 1st Detect, BreathTech, and AgLab. The company was founded in 1984 and is headquartered in Austin, TX.

Astrotech Corp

Astrotech Corp is experiencing extreme volatility and intense community discussion due to a massive, multi-day short squeeze driven by retail momentum and buzz surrounding speculative space-sector initiatives. While some traders are aggressively hunting for triple-digit price points, others are issuing warnings about potential dilution and the stock's lack of fundamental support, turning the symbol into a high-stakes battleground between bulls and bears.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is seeing increased investor activity as the company prepares for the June launch of its R2 model and works to expand its production and software footprint. Community discourse remains divided between long-term bulls highlighting recent production milestones and partnerships, and skeptics focused on broader market volatility and questions regarding profitability timelines.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing high volatility and heavy trading volume as investors react to a launchpad explosion involving Blue Origin, fueling concerns about potential satellite deployment delays despite the company's existing launch contracts with SpaceX and others. Community discussions remain polarized between panic-selling retail traders and long-term investors who view the sharp pullback as a buying opportunity, emphasizing the stock's fundamental technological milestones and upcoming commercial catalysts.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is rallying behind a blowout quarterly report featuring record-shattering AI server demand and a significantly raised outlook, fueling intense community discussion about the broadening AI infrastructure supercycle. Investors are actively debating the sustainability of this massive valuation re-rating while tracking how the stock's momentum impacts broader sector leaders and short positions.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is experiencing significant volatility following a mixed Q1 report, as investors weigh a beat on revenue and raised guidance against a slight EPS miss and lukewarm communication on the earnings call. The community remains deeply divided, with many long-term holders pointing to robust cash reserves, GAAP profitability, and a high short interest as catalysts for a potential squeeze, while others express frustration over the stock's lack of upward momentum relative to broader software sector gains.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing a surge in investor optimism driven by its massive AI cloud infrastructure backlog and expanding hyperscaler partnerships, fueling strong institutional call accumulation. The community is actively discussing the stock's potential for a major breakout as it approaches key resistance levels, with many traders viewing the current price action as a setup for a significant rally heading into the upcoming earnings report.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is capturing community attention ahead of its upcoming earnings report, with investors closely watching for updates on commercial production milestones for smart eyewear, drone market expansion, and the status of smartphone qualification frameworks. While short-term volatility persists due to ongoing debates over manufacturing scaling, the community remains divided between those betting on long-term disruptive potential in the wearable and defense sectors and those skeptical of past timeline delays.

Magnachip Semiconductor Corp. engages in the design and manufacture of analog and mixed-signal platform solutions for communications, Internet of Things (IoT), consumer, computing, industrial, and automotive applications. Its products include MOSFETs, IGBTs, AC-DC/DC-DC converters, light-emitting diode (LED) drivers, regulators, power management integrated circuits (PMICs), and industrial applications such as power suppliers, e-bikes, photovoltaic inverters, LED lighting, and motor drives. The company was founded on November 26, 2003 and is headquartered in Cheongju-si, South Korea.

MagnaChip Semiconductor Corp

MagnaChip Semiconductor is seeing heightened interest as investors eye its strategic pivot toward AI server and data center power solutions, evidenced by its upcoming showcase of MV MOSFET technology. The community is actively debating the company's valuation against its AI-focused product pipeline, with many participants speculating on its long-term potential in the high-demand power semiconductor sector.

VivoPower Plc focuses on developing and operating sustainable data center infrastructure that guarantees sovereign control over power, data, and national intelligence. It helps sovereign nations bridge the gap between their energy assets and their AI ambitions by providing the Power-to-X infrastructure necessary to build and control domestic intelligence hubs. The company operates globally with a presence across the United Kingdom, Australia, North America, Europe, the Middle East, and Southeast Asia. VivoPower was founded in 2014 and is headquartered in London, the United Kingdom.

VivoPower PLC.

VivoPower is seeing significant market momentum driven by the strategic pivot of its operational Norway data center into the high-demand AI infrastructure sector, with community attention focused on the upcoming June 30 deadline for selecting a tier-1 tenant. Investors are closely monitoring the stock due to its low float and high short interest, fueling speculation of a potential short squeeze as they await a major contract announcement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Viridian Therapeutics to Participate in Upcoming June Investor Conferences

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced that members of its management team will participate in the following upcoming investor...

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today...

Viridian Therapeutics (NASDAQ:VRDN) Given "Buy" Rating at Needham & Company LLC

Needham & Company LLC reaffirmed a "buy" rating and set a $32.00 price target on shares of Viridian Therapeutics in a research report on Tuesday...

Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock

Promising Biotech Stocks To Watch Today - May 5th

Vertex Pharmaceuticals, Danaher, and Viridian Therapeutics are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop and commercialize biological products and technologiessuch as novel drugs, gene thera...

Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Up  on Strong Earnings

Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Up Following Earnings Beat...

VRDN Stock Records Biggest Single Day Gains In 45 Months – And It’s Not Just Due To A Better-Than-Feared Q1 Loss

Equity

Viridian said that Elegrobart, its Thyroid Eye Disease therapy, met its primary endpoint in the REVEAL-2 Phase 3 study.

Markets On Fire: Biotech Breakthroughs and AI Mega-Deals Move Wall Street

$CLRB, $NTHI, $BLZE, $DGXX, $VRDN, $CYTK are among today's leading stocks

Viridian Therapeutics (NASDAQ:VRDN) Issues Earnings Results

Viridian Therapeutics (NASDAQ:VRDN - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.90) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.06) by $0.16. Viridian Therapeutics had a negative return on equity of 83.25% and a...

Viridian Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Progress

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today reported recent business highlights and financial results for the first quarter ended March 31...

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$1.03	--	--	N/A
Q1 '26	-$1.08	-$0.90	16.74%	BEAT
Q4 '25	-$0.98	-$1.08	-10.24%	MISSED
Q3 '25	-$1.02	-$0.34	66.62%	BEAT
Q2 '25	-$1.00	-$1.00	0.09%	BEAT

VRDN
Viridian Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest VRDN News

VRDNViridian Therapeutics Inc